Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Sectra's three-month interim report 2025/2026: Order bookings doubled following success in the US and Canada

(SECT) LINKÖPING, Sweden, Sept. 4, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) reports double order bookings, increased sales in all operati...

What risks or sustainability concerns exist for the rapid growth in the US and Canada markets, and how might they affect future guidance? What are the valuation implications relative to peers in the medical imaging IT and cybersecurity space, and how might the stock react in the short term? How will the doubled order bookings and higher sales impact SECT's revenue and earnings outlook for the full fiscal year?
Symbol: SECT
Earnings
3 days ago
Read more prnewswire

UK Insurers Gain Insight into Carbon Footprint of Claims with New Verisk Calculator

(NASDAQ:VERI) The Carbon Trust assures Verisk tool delivering industry-first emissions tracking for property claims The Carbon Trust assures Verisk tool delivering industry-first emissions trackin...

How fast might insurers adopt the Verisk tool, and could it create a sustainable competitive advantage for the company? What impact could this ESG-driven product have on VERI's valuation and investor sentiment relative to its peers? How will Verisk's new carbon footprint calculator affect its revenue and profit margins?
Symbol: VERI
Insurance
3 days ago
Read more globenewswire

Roche receives CE mark for Contivue, its Port Delivery Platform containing Susvimo, for neovascular age-related macular degeneration (nAMD)

(RO) Basel, 04 September 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received the EU CE mark for its Port Delivery Platform containing Susvimo, which will now be known as ...

When is the EMA decision expected for Susvimo, and what are the potential pricing and reimbursement implications in the EU market? What competitive advantages does Contivue offer over existing nAMD delivery platforms from companies like Novartis and Alcon, and how might this influence market share? How will the CE marking of Contivue with Susvimo affect Roche's upcoming quarterly earnings and revenue forecasts?
Symbol: RO
Regulatory approval
3 days ago
Read more globenewswire